AAAAAA
Results: 26-50/54
Authors:
Sandell, J
Langer, O
Larsen, P
Dolle, F
Vaufrey, F
Demphel, S
Crouzel, C
Halldin, C
Citation: J. Sandell et al., Improved specific radioactivity of the PET radioligand [C-11]FLB 457 by use of the GE Medical Systems PETtrace MeI MicroLab, J LABEL C R, 43(4), 2000, pp. 331-338
Authors:
Kamarainen, EL
Kyllonen, T
Airaksinen, A
Lundkvist, C
Yu, MX
Nagren, K
Sandell, J
Langer, O
Vepsalainen, J
Hiltunen, J
Bergstrom, K
Lotjonen, S
Jaakkola, T
Halldin, C
Citation: El. Kamarainen et al., Preparation of [F-18]beta-CFT-FP and [C-11]beta-CFT-FP, selective radioligands for visualisation of the dopamine transporter using positron emission tomography (PET), J LABEL C R, 43(12), 2000, pp. 1235-1244
Authors:
Langer, O
Gulyas, B
Sandell, J
Laszlovszky, I
Kiss, B
Domany, G
Acs, T
Farde, L
Halldin, C
Citation: O. Langer et al., Radiochemical labelling of the dopamine D-3 receptor ligand RGH-1756, J LABEL C R, 43(11), 2000, pp. 1069-1074
Authors:
Dolle, F
Bottlaender, M
Demphel, S
Emond, P
Fuseau, C
Coulon, C
Ottaviani, M
Valette, H
Loc'h, C
Halldin, C
Mauclaire, L
Guilloteau, D
Maziere, B
Crouzel, C
Citation: F. Dolle et al., Highly efficient synthesis of [C-11]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET, J LABEL C R, 43(10), 2000, pp. 997-1004
Authors:
Sandell, J
Halldin, C
Helfenbein, J
Chou, YH
Vercouillie, J
Emond, P
Swahn, CG
Guilloteau, D
Farde, L
Citation: J. Sandell et al., Synthesis of [C-11]2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-methyl, -ethyland isopropyl phenyl)nortropane as potential radiotracers for examination of the serotonin transporter with positron emission tomography, J LABEL C R, 43(10), 2000, pp. 1033-1046
Authors:
Bergstrom, KA
Yu, MX
Kuikka, JT
Akerman, KK
Hiltunen, J
Lehtonen, J
Halldin, C
Tiihonen, J
Citation: Ka. Bergstrom et al., Metabolism of [I-123]epidepride may affect brain dopamine D-2 receptor imaging with single-photon emission tomography, EUR J NUCL, 27(2), 2000, pp. 206-208
Authors:
Abi-Dargham, A
Martinez, D
Mawlawi, O
Simpson, N
Hwang, DR
Slifstein, M
Anjilvel, S
Pidcock, J
Guo, NN
Lombardo, I
Mann, JJ
Van Heertum, R
Foged, C
Halldin, C
Laruelle, M
Citation: A. Abi-dargham et al., Measurement of striatal and extrastriatal dopamine D-1 receptor binding potential with [C-11]NNC 112 in humans: Validation and reproducibility, J CEREBR B, 20(2), 2000, pp. 225-243
Authors:
Kaasinen, V
Nagren, K
Hietala, J
Oikonen, V
Vilkman, H
Farde, L
Halldin, C
Rinne, JO
Citation: V. Kaasinen et al., Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease, NEUROLOGY, 54(7), 2000, pp. 1482-1487
Authors:
Backman, L
Ginovart, N
Dixon, RA
Wahlin, TBR
Wahlin, A
Halldin, C
Farde, L
Citation: L. Backman et al., Age-related cognitive deficits mediated by changes in the striatal dopamine system, AM J PSYCHI, 157(4), 2000, pp. 635-637
Authors:
Chou, YH
Karlsson, P
Halldin, C
Olsson, H
Farde, L
Citation: Yh. Chou et al., A PET study of D-1-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain, PSYCHOPHAR, 146(2), 1999, pp. 220-227
Authors:
Andree, B
Thorberg, SO
Halldin, C
Farde, L
Citation: B. Andree et al., Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography, PSYCHOPHAR, 144(3), 1999, pp. 303-305
Authors:
Ito, H
Okubo, Y
Halldin, C
Farde, L
Citation: H. Ito et al., Mapping of central D-2 dopamine receptors in man using [C-11]raclopride: PET with anatomic standardization technique, NEUROIMAGE, 9(2), 1999, pp. 235-242
Authors:
Hall, H
Halldin, C
Guilloteau, D
Chalon, S
Emond, P
Besnard, JC
Farde, L
Sedvall, G
Citation: H. Hall et al., Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [I-125]PE2I, NEUROIMAGE, 9(1), 1999, pp. 108-116
Authors:
Okubo, Y
Olsson, H
Ito, H
Lofti, M
Suhara, T
Halldin, C
Farde, L
Citation: Y. Okubo et al., PET mapping of extrastriatal D2-like dopamine receptors in the human brainusing an anatomic standardization technique and [C-11]FLB 457, NEUROIMAGE, 10(6), 1999, pp. 666-674
Authors:
Gulyas, B
Halldin, C
Karlsson, P
Chou, YH
Swahn, CG
Bonock, P
Paroczai, M
Farde, L
Citation: B. Gulyas et al., Brain uptake and plasma metabolism of [C-11]vinpocetine: A preliminary PETstudy in a cynomolgus monkey, J NEUROIMAG, 9(4), 1999, pp. 217-222
Authors:
Helfenbein, J
Sandell, J
Halldin, C
Chalon, S
Emond, P
Okubo, Y
Chou, YH
Frangin, Y
Douziech, L
Gareau, L
Swahn, CG
Besnard, JC
Farde, L
Guilloteau, D
Citation: J. Helfenbein et al., PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter, NUCL MED BI, 26(5), 1999, pp. 491-499
Authors:
Lundkvist, C
Loc'h, C
Halldin, C
Bottlaender, M
Ottaviani, M
Coulon, C
Fuseau, C
Mathis, C
Farde, L
Maziere, B
Citation: C. Lundkvist et al., Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter, NUCL MED BI, 26(5), 1999, pp. 501-507
Authors:
Langer, O
Halldin, C
Dolle, F
Swahn, CG
Olsson, H
Karlsson, P
Hall, H
Sandell, J
Lundkvist, C
Vaufrey, F
Loc'h, C
Crouzel, C
Maziere, B
Farde, L
Citation: O. Langer et al., Carbon-11 epidepride: A suitable radioligand for PET investigation of striatal and extrastriatal dopamine D-2 receptors, NUCL MED BI, 26(5), 1999, pp. 509-518
Authors:
Lundkvist, C
Halldin, C
Swahn, CG
Ginovart, N
Farde, L
Citation: C. Lundkvist et al., Different brain radioactivity curves in a PET study with [C-11]beta-CIT labelled in two different positions, NUCL MED BI, 26(4), 1999, pp. 343-350
Authors:
Sandell, J
Halldin, C
Hall, H
Thorberg, SO
Werner, T
Sohn, D
Sedvall, G
Farde, L
Citation: J. Sandell et al., Radiosynthesis and autoradiographic evaluation of [C-11]NAD-299, a radioligand for visualization of the 5-HT1A receptor, NUCL MED BI, 26(2), 1999, pp. 159-164
Authors:
Abi-Dargham, A
Simpson, N
Kegeles, L
Parsey, R
Hwang, DR
Anjilvel, S
Zea-Ponce, Y
Lombardo, I
Van Heertum, R
Mann, JJ
Foged, C
Halldin, C
Laruelle, M
Citation: A. Abi-dargham et al., PET studies of binding competition between endogenous dopamine and the D-1radiotracer [C-11]NNC 756, SYNAPSE, 32(2), 1999, pp. 93-109
Authors:
Ginovart, N
Farde, L
Halldin, C
Swahn, CG
Citation: N. Ginovart et al., Changes in striatal D-2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates, SYNAPSE, 31(2), 1999, pp. 154-162
Authors:
Helfenbein, J
Emond, P
Sandell, J
Halldin, C
Pereyre, S
Frangin, Y
Garreau, L
Besnard, JC
Guilloteau, D
Chalon, S
Citation: J. Helfenbein et al., Synthesis and radiolabelling of 2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-isopropylphenyl) nortropane as a radioligand for the exploration of the serotonin transporter by SPET., J LABEL C R, 42(4), 1999, pp. 337-347
Authors:
Langer, O
Nagren, K
Dolle, F
Lundkvist, C
Sandell, J
Swahn, CG
Vaufrey, F
Crouzel, C
Maziere, B
Halldin, C
Citation: O. Langer et al., Precursor synthesis and radiolabelling of the dopamine D-2 receptor ligand[C-11]raclopride from [C-11]methyl triflate, J LABEL C R, 42(12), 1999, pp. 1183-1193
Authors:
Bergstrom, KA
Halldin, C
Savonen, A
Okubo, Y
Hiltunen, J
Nobuhara, K
Swahn, CG
Karlsson, P
McPherson, D
Knapp, FF
Larsson, S
Schnell, PO
Farde, L
Citation: Ka. Bergstrom et al., Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M-1 and M-2 muscarinic acetylcholine receptors in Alzheimer's disease, EUR J NUCL, 26(11), 1999, pp. 1482-1485